Shanghai Pharmaceutical Co., Ltd (SPH, SHA: 601607, HKG: 2607), a leading pharmaceutical company based in China, has entered into a partnership with fellow Chinese firm Sino Biopharmaceutical Ltd (HKG: 1177). Under the agreement, Sino Bio will prioritize Shanghai Pharma as its strategic partner in the Chinese region under equal conditions, with a focus on exploring collaboration in export services, distribution services, and bidding services.
Shanghai Pharma will utilize its nationwide logistics system to provide timely, accurate, and efficient drug delivery services for Sino Bio, as well as innovative payment solutions that benefit patients. Financial details of the partnership were not disclosed.
In the realm of pre-market services for innovative drugs, Shanghai Pharma will leverage its platform in the Lingang section of the Shanghai Pilot Free Trade Zone to offer various service supports for Sino Bio, including drug regulatory filings, clinical trials, and bonded warehousing, aiding Sino Bio in better completing drug research and registration work.
The partnership also aims to expand cooperation in overseas business, with Shanghai Pharma using its advantageous resources to provide high-quality import and export supply-chain services, actively exploring overseas markets, and cooperating with Sino Bio to supply products to these markets.- Flcube.com
